Sugi Predict

Sugi Predict / Compounds / SCHEMBL2268694

SCHEMBL2268694

SCHEMBL2268694

CC1(C)OB(c2ccc3ccccc3n2)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 2/20 0.45
▸ LIPG Q9Y5X9 2/20 0.45
▸ CYP1A2 P05177 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ NCF1 P14598 3/20 0.40
▸ NOS2 P35228 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ LMNA P02545 2/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29781408 1.00 LPL (0.45) LPLLIPGCYP1A2HTTNCF1
SCHEMBL360717 0.85 LPL (0.49) LPLLIPGHTTLMNAALDH1A1
SCHEMBL21808930 0.84 RAB9A (0.40) LPLLIPGCYP1A2HTTLMNA
SCHEMBL29254215 0.80 LIPG (0.55) LPLLIPGBACE1
SCHEMBL20769136 0.78 ALDH1A1 (0.37) LPLLIPGHTTLMNAALDH1A1
SCHEMBL360716 0.78 LPL (0.42) LPLLIPGCYP1A2ALDH1A1NPC1
SCHEMBL20295219 0.77 ALDH1A1 (0.40) LPLLIPGHTTALDH1A1NPC1
SCHEMBL14884184 0.76 ALDH1A1 (0.41) LPLLIPGCYP1A2HTTLMNA
SCHEMBL14884188 0.76 ALDH1A1 (0.41) LPLLIPGCYP1A2HTTLMNA
SCHEMBL22963565 0.74 HPRT1 (0.41) LPLLIPGLMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117756832-A Synthesis method of quinoline-2-boronic acid pinacol ester 郑州海阔光电材料有限公司 2024-03-26 — — CN claimed
US-20250313567-A1 IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS INCYTE CORPORATION 2025-10-09 — — US disclosed
EP-4558478-A1 ARYL HYDROCARBON RECEPTOR AGONIST PRODRUGS AND METHODS OF USE THEREOF Allianthera (Suzhou) Biopharmaceutical Co., Ltd. (CN) 2025-05-28 — — EP disclosed
CN-118355014-A Novel compound and organic light emitting device comprising the same 株式会社LG化学 2024-07-16 — — CN disclosed
CN-117756832-A Synthesis method of quinoline-2-boronic acid pinacol ester 郑州海阔光电材料有限公司 2024-03-26 — — CN disclosed
CN-117756832-A Synthesis method of quinoline-2-boronic acid pinacol ester 郑州海阔光电材料有限公司 2024-03-26 — — CN disclosed
CN-117756832-A Synthesis method of quinoline-2-boronic acid pinacol ester 郑州海阔光电材料有限公司 2024-03-26 — — CN disclosed
WO-2024049067-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2024-03-07 — — WO disclosed
WO-2024049067-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2024-03-07 — — WO disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 — — US disclosed
CN-111601809-A Triazolo-pyrimidine compounds and uses thereof 迪哲（江苏）医药有限公司 2020-08-28 — — CN disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 — — US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 — — US disclosed
WO-2019004599-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 2019-01-03 — — WO disclosed
WO-2019004599-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 2019-01-03 — — WO disclosed
US-8628863-B2 Indenopyrene compound and organic light-emitting device using the compound CANON KABUSHIKI KAISHA (JP) 2014-01-14 — — US disclosed
WO-2012149157-A2 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2012-11-01 — — WO disclosed
US-20110204354-A1 INDENOPYRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2011-08-25 — — US disclosed
EP-1740591-A1 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS OSI Pharmaceuticals, Inc. (US) 2007-01-10 — — EP disclosed
WO-2005097800-A1 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2005-10-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 LPL 543/4885LIPG 990/4885CYP1A2 1582/4885
US-20250313567-A1 IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS ADORA2A, ADORA2B, ADORA1 LPL 4054/4885LIPG 3519/4885CYP1A2 137/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 LPL 543/4885LIPG 990/4885CYP1A2 1582/4885
US-20110204354-A1 INDENOPYRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND PPOX, TYR, CACNA2D2 LPL 1731/4885LIPG 2888/4885CYP1A2 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback